The healthcare-focused advisory group said it saw “good growth” in revenues and earnings, while profit margins were slightly higher than the comparable period last year.
The Cello Health division had a “robust” first-half, with "excellent" like-for-like gross profit growth, investors were told.
Cello Signal was described as having had a “solid” start to the year. The company said while gross profit had declined slightly year-on-year, but margins have increased, meaning operating profits will expand slightly.
The businesses acquired last year are now fully absorbed into Cello and “continue to make a good contribution”, the company said.